Suki, an Artificial Intelligence (AI) technology company that provides AI voice solutions for healthcare, has raised USD 70 million in a Series D round, bringing its total funding to USD 165 million. The latest round, led by Hedosophia with substantial additional investment from Venrock and other existing investors, including March Capital, Flare Capital, Breyer Capital, and inHealth Ventures, will drive product development, commercial initiatives, and leadership expansion.
Suki plans to use the new investment to accelerate product development and expand beyond its current offerings. Its AI-powered solutions include Suki Assistant, an AI assistant that streamlines administrative tasks for clinicians, and the Suki Platform, a suite of developer tools for technology partners building AI experiences in their solutions.
Suki Assistant: Streamlining Clinical Workflows
Suki claims its Assistant helps clinicians save time on tedious administrative tasks by generating notes ambiently, taking dictation and commands, simplifying coding, and answering clinical questions by retrieving relevant chart data from the EHR (electronic health record).
“Suki has been growing at an exponential rate, with over a dozen major health systems and hospitals deploying or expanding access to Suki in the last two months alone,” the company said.
“We are in a new phase of growth. The healthcare industry is clamoring for AI and we are proud to offer a suite of full-featured solutions that seamlessly interoperate with existing tools,” said Punit Soni, CEO and founder of Suki.
“With the support of our investors, we’ll accelerate our growth, diversify Suki’s capabilities, and deepen relationships with strategic partners such as MedStar Health, one of the most important collaborators in Suki’s history. MedStar Health was fundamental in helping us build essential capabilities including our bidirectional and seemingly ‘invisible’ EHR integration, which is why we have the highest clinician adoption rates in the industry. Together, we have demonstrated how a technology company and health system can meaningfully innovate together and advance physician well-being and patient care.”
The platform integrates with EHR systems like Epic, Oracle Cerner, and Meditech, allowing for faster documentation and improved workflow efficiency. The company also collaborates with Athena. According to Suki, the Assistant’s ability to reduce documentation time by 72 percent has led to a 70 percent adoption rate across health systems.
“Health systems experience note completion up to 72 percent faster while increasing documentation quality, improving clinician well-being, and enhancing revenue capture,” the company said.
“Since our seed investment in Suki, the company has grown exponentially by securing strategic partnerships with leading health systems and healthtech companies, and demonstrating meaningful impact to all stakeholders, from clinicians to administrators,” said Bryan Roberts, Partner at Venrock. “Suki is well on its way to becoming the de facto AI platform for healthcare and we are proud to support it as it continues its rapid growth.”
Additionally, Suki has expanded its strategic partnership with MedStar Health. This agreement makes Suki’s Assistant available to thousands of MedStar Health clinicians across various ambulatory specialties, including primary care, cardiology, and gastroenterology, as well as in urgent care settings.
“As MedStar Health explores and deploys artificial intelligence capabilities that can revolutionise healthcare delivery, Suki has served as a critical partner in our ongoing journey for more than four years,” said Jeff Collins, vice president of the MedStar Institute for Innovation Business Innovation Lab.
Recent announcements highlight partnerships with health systems (Ascension Saint Thomas, St. Mary’s Hospital, Decatur County Memorial Hospital), healthcare technology companies (Meditech, Amwell), and group purchasing organisations (Premier, omo), according to Suki.
Some people read for free. A few choose to support. If you found TelecomTalk useful, you can help keep us running.
Support Telecomtalk
